• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session

    5/6/24 12:32:34 PM ET
    $AESI
    $BAK
    $BCRX
    $BOWL
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials
    Major Chemicals
    Industrials
    Get the next $AESI alert in real time by email

    Shares of Perficient, Inc (NASDAQ:PRFT) shares rose sharply during Monday's session after the company disclosed an acquisition deal and first-quarter FY24 results.

    The company stated that it has entered into a definitive deal to be acquired by an affiliate of BPEA Private Equity Fund VIII (EQT Asia), part of EQT AB in an all-cash transaction at an enterprise value of around $3.0 billion.

    Perficient shares jumped 53% to $73.60 on Monday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 19% to $5.30 following strong first-quarter results.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) rose 15% to $2.1050.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 13.2% to $19.83.
    • Trupanion, Inc. (NASDAQ:TRUP) rose 10.9% to $22.02. The company recently reported first-quarter financial results.
    • Ocugen, Inc. (NASDAQ:OCGN) surged 10.9% to $1.4750. Ocugen is expected to host conference call on Tuesday, May 14 to discuss business updates and first quarter 2024 financial results.
    • SNDL Inc. (NASDAQ:SNDL) shares gained 10.5% to $2.5999.
    • SelectQuote, Inc. (NYSE:SLQT) jumped 10.3% to $2.25. SelectQuote is expected to Release fiscal third quarter 2024 earnings on May 9.
    • Lotus Technology Inc. (NASDAQ:LOT) gained 9.4% to $7.80.
    • Atlas Energy Solutions Inc. (NASDAQ:AESI) rose 7.7% to $23.65, reversing from earlier weakness after reporting first-quarter results. The company also raised its dividend.

    Losers

    • EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) dipped 37.7% to $12.29 after the company’s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.
    • Integra LifeSciences Holdings Corporation (NASDAQ:IART) shares dropped 17.8% to $23.76 following weak second-quarter EPS guidance.
    • Bowlero Corp. (NYSE:BOWL) fell 16.7% to $10.40 in pre-market trading after posting weaker-than-expected quarterly results.
    • Braskem S.A. (NYSE:BAK) shares declined 15.5% to $7.63 in pre-market trading after shareholder Novonor said Adnoc has no interest in continuing the process on a potential transaction.
    • GameStop Corp. (NYSE:GME) fell 15.2% to $13.97 after the stock rose more than 40% last week.
    • Uniti Group Inc. (NASDAQ:UNIT) fell 11.5% to $3.9489 after the company announced plans for a $300 million offering of 10.50% Senior Secured Notes due 2028 by its subsidiaries.
    • TreeHouse Foods, Inc. (NYSE:THS) dipped 10.3% to $33.41 after the company reported mixed first-quarter financial results including a net sales decline.
    • Spirit Airlines, Inc. (NYSE:SAVE) declined 9.8% to $3.3450 as the company reported a first-quarter fiscal 2024 revenue decline of 6.2% Y/Y to $1.265 billion, marginally missing the consensus of $1.269 billion.
    • Critical Metals Corp. (NASDAQ:CRML) fell 7.9% to $9.18.
    • Tyson Foods, Inc. (NYSE:TSN) fell 7.8% to $57.18 following weak quarterly sales.

    Now Read This: How To Earn $500 A Month From FMC Stock Ahead Of Q1 Earnings

    Get the next $AESI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AESI
    $BAK
    $BCRX
    $BOWL

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    BioCryst Pharmaceuticals Inc.
    $BCRX
    2/18/2026$17.00Outperform
    Evercore ISI
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Tyson Foods Inc.
    $TSN
    1/8/2026$67.00Market Perform → Outperform
    BMO Capital Markets
    MARA Holdings Inc.
    $MARA
    11/24/2025$30.00Neutral → Buy
    Compass Point
    Atlas Energy Solutions Inc.
    $AESI
    11/21/2025$8.00Neutral → Sell
    Goldman
    Atlas Energy Solutions Inc.
    $AESI
    11/14/2025Equal Weight → Underweight
    Barclays
    Uniti Group Inc.
    $UNIT
    10/23/2025$7.00Neutral
    Analyst
    More analyst ratings

    $AESI
    $BAK
    $BCRX
    $BOWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    Evercore ISI resumed coverage on BioCryst Pharma with a new price target

    Evercore ISI resumed coverage of BioCryst Pharma with a rating of Outperform and set a new price target of $17.00

    2/18/26 8:21:17 AM ET
    $BCRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Morgan Stanley initiated coverage on MARA Holdings Inc. with a new price target

    Morgan Stanley initiated coverage of MARA Holdings Inc. with a rating of Underweight and set a new price target of $8.00

    2/9/26 7:01:42 AM ET
    $MARA
    EDP Services
    Technology

    $AESI
    $BAK
    $BCRX
    $BOWL
    SEC Filings

    View All

    Uniti Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Uniti Group Inc. (0002020795) (Filer)

    3/2/26 8:10:42 AM ET
    $UNIT
    Real Estate Investment Trusts
    Real Estate

    EyePoint Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - EyePoint, Inc. (0001314102) (Filer)

    3/2/26 7:05:30 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    2/27/26 5:31:00 PM ET
    $BAK
    Major Chemicals
    Industrials

    $AESI
    $BAK
    $BCRX
    $BOWL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Uniti Group Inc. Reports Fourth Quarter and Full Year 2025 Results

          Recently Completed Inaugural Kinetic ABS and Refinancing Activity Strengthens Uniti's Balance Sheet at Attractive Cost of Capital       Signed Largest Customer Contract in Uniti's History with Prominent Hyperscaler       Provides Full Year 2026 Outlook Net Loss of $305.7 Million for the Fourth Quarter and Net Income of $1,304.7 Million for the Full YearConsolidated Revenue and Adjusted EBITDA of $917.3 Million and $365.6 Million, Respectively, for the Fourth QuarterConsolidated Revenue and Adjusted EBITDA of $2,234.5 Million and $1,173.8 Million, Respectively, for the Full Year LITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. ("Uniti" or the "Company") (NASD

    3/2/26 8:00:00 AM ET
    $UNIT
    Real Estate Investment Trusts
    Real Estate

    Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa

    Enrollment for liMeliGhT, the first and largest gene therapy registrational trial for broad retinitis pigmentosa (RP) patients, was completed, reflecting strong interest from investigators and patientsTopline Phase 3 data expected in 1Q 2027, advancing OCU400 towards potential approval in 2027 as a treatment option for early- to late-stage RPPositive long-term, 3-year Phase 1/2 durable, safety and tolerability data for OCU400 demonstrates sustained clinically meaningful, approximately 2-line LLVA gain, reinforcing durable gene-agnostic benefit MALVERN, Pa., March 02, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology leader in gene ther

    3/2/26 7:02:00 AM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema

    – Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets – – Topline data for DURAVYU in DME anticipated in 2H 2027 – WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the first patient dosed in both Phase 3 COMO and CAPRI global clinical trials of DURAVYU™ (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME). DURAVYU is an investigational sustained delivery therapy delivering vorolanib, a selective tyrosine ki

    3/2/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AESI
    $BAK
    $BCRX
    $BOWL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Grant Robert Clay bought $105,024 worth of shares (118,901 units at $0.88) (SEC Form 4)

    4 - SelectQuote, Inc. (0001794783) (Issuer)

    2/19/26 4:11:41 PM ET
    $SLQT
    Specialty Insurers
    Finance

    Large owner Silver Point Capital L.P. bought $8,783,283 worth of shares (357,917 units at $24.54) (SEC Form 4)

    4 - TreeHouse Foods, Inc. (0001320695) (Issuer)

    2/12/26 8:35:21 PM ET
    $THS
    Packaged Foods
    Consumer Staples

    Director Cheng Lawrence bought $114,368 worth of shares (5,000 units at $22.87) (SEC Form 4)

    4 - GameStop Corp. (0001326380) (Issuer)

    1/26/26 9:06:47 AM ET
    $GME
    Electronics Distribution
    Consumer Discretionary

    $AESI
    $BAK
    $BCRX
    $BOWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Administration Officer Mcgibney Brenna converted options into 646 shares and covered exercise/tax liability with 343 shares, increasing direct ownership by 4% to 8,453 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    2/27/26 8:03:14 PM ET
    $TRUP
    Medical Specialities
    Health Care

    CEO Tooth Margaret converted options into 4,516 shares and covered exercise/tax liability with 1,776 shares, increasing direct ownership by 2% to 164,829 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    2/27/26 8:03:19 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Director Rawlings Darryl converted options into 946 shares, increasing direct ownership by 2% to 42,232 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    2/27/26 8:03:07 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $AESI
    $BAK
    $BCRX
    $BOWL
    Leadership Updates

    Live Leadership Updates

    View All

    EyePoint Appoints Michael Campbell as Chief Commercial Officer

    – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell has been appointed Chief Commercial Officer. Mr. Campbell, an experienced commercial leader with a proven track record of successful product launches and oversight of

    2/18/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Integra LifeSciences Announces Key Executive Leadership Appointments

    PRINCETON, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the appointment of Teshtar Elavia as corporate vice president and chief technology officer, a newly created position to lead research and development (R&D), including product and technology development, across the company. The company also announced the appointments of Michael Hutchinson as executive vice president, chief legal officer and secretary, and Kerri DiPietro as corporate vice president and chief quality officer. The creation of the chief technology officer (CTO) position underscores Integra's commitment to build

    2/17/26 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Vongvanith Named Kinetic's First Chief Customer Officer; Brings Customer Voice to Senior Leadership

    LITTLE ROCK, Ark., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kinetic, a leader in residential and business fiber internet, has elevated the customer voice with the creation of its new chief customer officer role. The position, which is the first of its kind at Kinetic, underscores the company's customer-obsessed approach and commitment to delivering better technology, service, value and experience for customers. Industry leader Stacie Vongvanith will be Kinetic's first CCO. Drawing on her years of telecom, cable and fiber internet experience, Vongvanith will enhance Kinetic's customer experience, identify pain points and act quickly to solve them, helping the company continue to raise the bar for

    2/17/26 8:00:00 AM ET
    $UNIT
    Real Estate Investment Trusts
    Real Estate

    $AESI
    $BAK
    $BCRX
    $BOWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Critical Metals Corp.

    SC 13D/A - Critical Metals Corp. (0001951089) (Subject)

    12/13/24 4:10:59 PM ET
    $CRML
    Metal Mining
    Basic Materials

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/26/24 8:27:01 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AESI
    $BAK
    $BCRX
    $BOWL
    Financials

    Live finance-specific insights

    View All

    Uniti Group Inc. Reports Fourth Quarter and Full Year 2025 Results

          Recently Completed Inaugural Kinetic ABS and Refinancing Activity Strengthens Uniti's Balance Sheet at Attractive Cost of Capital       Signed Largest Customer Contract in Uniti's History with Prominent Hyperscaler       Provides Full Year 2026 Outlook Net Loss of $305.7 Million for the Fourth Quarter and Net Income of $1,304.7 Million for the Full YearConsolidated Revenue and Adjusted EBITDA of $917.3 Million and $365.6 Million, Respectively, for the Fourth QuarterConsolidated Revenue and Adjusted EBITDA of $2,234.5 Million and $1,173.8 Million, Respectively, for the Full Year LITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) -- Uniti Group Inc. ("Uniti" or the "Company") (NASD

    3/2/26 8:00:00 AM ET
    $UNIT
    Real Estate Investment Trusts
    Real Estate

    MARA Announces Fourth Quarter and Fiscal Year 2025 Results

    Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA's website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss these financial results. To register to participate in the conference call, please use

    2/26/26 4:20:00 PM ET
    $MARA
    EDP Services
    Technology

    MARA Announces Strategic Partnership with Starwood to Accelerate Delivery of Cutting Edge Hyperscale, Enterprise and AI Capable Digital Infrastructure

    Joint Platform Expected to Deliver Approximately 1 GW of Near-Term IT Capacity, with Pathway to More than 2.5 GW  Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ:MARA), a leading energy and compute infrastructure company, today announced it has entered into a strategic agreement with Starwood Capital Group ("Starwood") and their dedicated data center development platform Starwood Digital Ventures ("SDV"). The partnership will enable the conversion and expansion of select MARA sites into next generation digital infrastructure capable of meeting the growing demand from enterprise, hyperscale and AI customers. Together, MARA and Starwood will jointly develop, financ

    2/26/26 4:15:00 PM ET
    $MARA
    EDP Services
    Technology